New insight into calcinosis of juvenile dermatomyositis: A study of composition and treatment

被引：92

作者：

Mukamel, M

Horev, G

Mimouni, M

机构：

[1] Schneider Childrens Med Ctr Israel, Pediat Rheumatol Unit, IL-49202 Petah Tiqwa, Israel

[2] Schneider Childrens Med Ctr Israel, Pediat Imaging Dept, IL-49202 Petah Tiqwa, Israel

[3] Schneider Childrens Med Ctr Israel, Day Care Unit, IL-49202 Petah Tiqwa, Israel

[4] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel

来源：

JOURNAL OF PEDIATRICS | 2001年 / 138卷 / 05期

关键词：

D O I：

10.1067/mpd.2001.112473

中图分类号：

R72 [儿科学];

学科分类号：

100202 ;

摘要：

Milk of calcium developed in 2 children with juvenile dermatomyositis. The fluid of the collection contained macrophages, interleukin-6, IL-I, and tumor necrosis factor. The patient who had dystrophic calcinosis had a dramatic improvement with the introduction of alendronate. These findings suggest that calcinosis of juvenile dermatomyositis may be mediated by activated macrophages and that alendronate can be an effective treatment for this condition.

引用

页码：763 / 766

页数：4

共 22 条

[1]

ANSELL BM, 1991, RHEUM DIS CLIN N AM, V17, P931

[2] MYOSITIS-OSSIFICANS PROGRESSIVA - A 10-YEAR FOLLOW-UP ON A PATIENT TREATED WITH ETIDRONATE DISODIUM [J].